Cypress Bioscience Acquires Novel Intranasal Carbetocin Therapy for Autism - MarketWatch (press release)

Cypress Bioscience Acquires Novel Intranasal Carbetocin Therapy for Autism MarketWatch (press release) Since 1999, Cypress has received multiple FDA approvals, including for Prosorba(TM), a medical device for rheumatoid arthritis, and Savella(R) (milnacipran ... and more »

Painful Debilitating Disease More Devastating than Previously Recognized - Food Consumer

Painful Debilitating Disease More Devastating than Previously Recognized Food Consumer By Dr. Mercola Rheumatoid arthritis affects about 1 percent of our population and at least two million Americans have definite or classical rheumatoid ... Painful Debilitating Disease More Devastating than Previously Recognized (2)Food Consumer all 2 news articles »

New RA Criteria Focus on Early Dx - MedPage Today

New RA Criteria Focus on Early Dx MedPage Today Explain to interested patients that new criteria for the classification of rheumatoid arthritis have been ... and more »

Redefining arthritis so fewer are disabled - UPI.com

Health Newstrack

Redefining arthritis so fewer are disabled UPI.com 17 (UPI) -- New criteria for rheumatoid arthritis will help prevent the disease from crippling patients, US and European doctors say. ... New rheumatoid arthritis criteria aimed at stopping disease in early onsetOrtho SuperSite all 11 news articles »